查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198540

手术显微镜市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Surgical Microscopes Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 121 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在 2022 年至 2027 年的预测期内，手术显微镜市场预计将以 10.89% 的复合年增长率增长。

据世界卫生组织 (WHO) 称，COVID-19 具有传染性，许多感染该病毒的人会出现轻度至中度呼吸道疾病。 COVID-19 的高感染率已经并继续给美国等国家的经济和医疗系统带来压力。 由于实施国家隔离、暂停与其他国家的贸易、旅行限制等，全球主要公司的市值有所下降。 不过，随着疫苗接种覆盖率的提高，情况正在逐渐好转。 由于 COVID-19 相关措施而推迟择期手术，特别是在 2020 年只允许进行紧急手术，这对手术显微镜市场产生了不利影响。 由于资源被用于 COVID-19 患者，大多数心臟手术被取消或推迟。 然而，随着疫苗接种覆盖率的提高，进行的手术数量也随之增加，这对市场产生了重大影响。 在感染率高的地区，手术室临时改建为辅助呼吸室。 术后恢復室和中级护理病房现在被用作普通重症监护病房以外的护理病房，以管理 COVID-19 患者。 例如，根据《英国外科杂誌》发表的一项研究，2020 年 5 月全球约有 2840 万次择期手术因 COVID-19 导致医院服务中断长达 12 周而被取消或推迟，这表明负面影响COVID-19 对所研究市场的影响。

市场驱动力包括微创手术的普及、老年人口的增加和慢性病负担的增加，以及手术显微镜的技术进步。

由于出生率下降和预期寿命延长，世界人口正在迅速老龄化。 例如，根据联合国《2020 年世界人口展望》，65 岁及以上的人口可能会从 2020 年的 9.3% 增长到 2050 年的 16% 以上。 因此，与年龄相关的慢性疾病和相关外科手术变得更加普遍，市场也在不断扩大。

手术显微镜已成为牙科、耳鼻喉科、神经外科、眼科和整容手术中微创外科手术的必备工具。 该产品的技术进步大大提高了视觉、定位、稳定性、尺寸和记录能力，有助于集成图像引导显微镜系统以获得更好的结果。

手术显微镜提供最佳照明、3D 可视化、通过小入路深度放大手术区域等等。 它还可以通过在执行复杂而冗长的手术时调整姿势来使外科医生受益。 预计这些因素将在预测期内推动市场。

但是，在预测期内，缺乏熟练的专业人员和高成本导致的接受度低等因素可能会阻碍市场增长。

手术显微镜的市场趋势

妇科和泌尿科领域有望占据较大市场份额

COVID-19 大流行对妇科和泌尿科领域产生了重大影响。 大流行极大地影响了外科服务。 根据一项名为 COVIDSurg Collaborative 的研究，2020 年 5 月，由于 COVID-19 流行病，约有 250 万例良性泌尿外科手术被取消。 然而，择期手术和急诊手术正在恢復，这可能会增加泌尿科和妇科疾病对手术显微镜的需求。

手术显微镜的应用范围很广，但妇科和泌尿科是最常见的应用，因为涉及的程序很多。 泌尿科和妇科疾病在世界范围内不断增加，手术显微镜存在的意义也越来越大。 例如，尿路感染 (UTI) 是影响所有年龄段人群的最常见的微生物疾病之一。 根据一项名为《泌尿系统感染流行病学：全球负担》的研究，世界泌尿外科杂誌，2020 年 1 月，大约有 1.5 亿人受到社区获得性尿路感染 (CAUTI) 的影响。 越来越多的目标疾病和越来越复杂的治疗导致了先进技术的采用，包括手术显微镜。

在妇科和泌尿科实践中，显微镜用于癌症检测、激光手术和诊断。 结肠镜检查或内窥镜检查可让您看到肠道和大肠的内部，从而便于手术。 由于与排便有关的疾病增加，结肠镜检查和内窥镜检查被广泛使用，预计将在预测期内推动整个市场。

北美有望在预测期内主导市场

该地区的市场增长是由先进设备的可用性、精密设施、熟练的神经外科医生和整容外科医生的存在、手术设施的增加、对门诊环境的偏好以及对医疗实践的支持所推动的。看来美国是主要负责医疗费用框架。

美国承受着巨大的慢性病负担，例如癌症、心血管疾病 (CVD) 和神经系统疾病。 美国疾病控制与预防中心 (CDC) 估计，2010 年至 2020 年期间，美国每年新增癌症病例数将增加 24%，男性超过 100 万，女性约 21 例。据说每年有可能超过 900,000 人，这是一个 % 的增长。 这样，由于慢性病的增加和治疗的复杂性，使用手术显微镜的先进技术开始被采用。

技术先进的产品的推出推动了对手术显微镜的需求，因为它们提供了更好的照明源、更准确，并提供了根据程序的复杂性进行定制和技术集成的选项。支持 例如，2020 年 9 月，True Digital Surgery (TDS) 和 Aesculap Inc. 在美国推出了 Aesculap Aeos 机器人数字显微镜。 因此，此类技术先进产品的推出有望推动区域市场的增长。

但是，COVID-19 病例数量的增加可能会对北美手术显微镜市场的增长产生负面影响，因为它会影响大多数公司的供应链。 暂时停止使用手术显微镜等设备，以遏製手术设备的病毒污染。 然而，结肠镜和内窥镜等手术器械是外科手术不可或缺的一部分，因此预计不会产生长期影响。

手术显微镜市场竞争者分析

手术显微镜市场竞争激烈，由多家大型企业组成。 Alcon、Alltion（梧州）、ARI Medical Technology、Metall Zug（Haag-Streit）、Danaher Corporation、Olympus Corporation、Seiler Instrument Inc、Takagi Seiko、Topcon 和 Carl Zeiss AG 等公司占据了相当大的市场份额。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 越来越多地采用微创手术
    • 老龄化社会的到来和慢性病的增加
    • 手术显微镜的技术进步
  • 市场製约因素
    • 缺乏熟练的专业人员
    • 成本高，接受度低
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 通过申请
    • 牙科
    • 妇科/泌尿科
    • 耳鼻喉科（耳鼻喉科）
    • 神经外科/脊柱外科
    • 肿瘤科
    • 眼科
    • 骨科和整形外科
    • 其他用途
  • 最终用户
    • 医院
    • 牙科诊所
    • 其他最终用户
  • 区域信息
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Alcon Inc.
    • Alltion（Wuzhou）Co. Ltd
    • ARI Medical Technology Co. Ltd
    • ATMOS MedizinTechnik GmbH & Co. KG
    • Avante Health Solutions
    • Carl Zeiss AG
    • HAAG-STREIT Surgical GmbH
    • Danaher Corporation（Leica Microsystems）
    • Metall Zug Group（Haag-Streit）
    • Olympus Corporation
    • Optofine Instruments Pvt. Ltd
    • Seiler Instrument Inc.
    • Synaptive Medical
    • Takagi Seiko Co. Ltd
    • Topcon Corporation

第7章 市场机会与今后动向

简介目录
Product Code: 61911

The surgical microscope market is expected to record a CAGR of 10.89% over the forecast period, 2022-2027.

As per the World Health Organization (WHO), COVID-19 is infectious, and most people infected by the virus experience mild to moderate respiratory illness. Due to the high transmission rate of COVID-19, countries like the United States have suffered and are continuing to bear a significant burden on their economies and healthcare systems. The country has been in lockdown, suspended trade with other countries, and implemented travel restrictions, leading to a decline in the market capitalization of major companies worldwide. However, the situation has improved gradually with an increase in the vaccination rate. The delay of elective procedures due to COVID-19-related measures has adversely affected the surgical microscopes market, especially in 2020, as only urgent surgeries were allowed. Most cardiac procedures were canceled or postponed due to the diversion of resources toward the COVID-19 infected patients. However, with the increasing vaccination rates, the number of surgeries performed also increased, significantly impacting the market. Operating theaters were temporarily converted to respiratory support units in regions with a high disease burden. Postoperative recovery rooms and intermediate care units were used as care units outside regular intensive care to manage sick patients affected by COVID-19. For instance, according to the study published in the British Journal of Surgery, in May 2020, based on a 12-week period of peak disruption to hospital services due to COVID-19, around 28.4 million elective surgeries worldwide were canceled or postponed, thus indicating the negative impact of COVID-19 on the market studied.

Certain factors driving the market include the increasing adoption of minimally invasive surgeries, the rising geriatric population and burden of chronic diseases, and technological advancements in surgical microscopes.

The global population is aging rapidly due to reduced birth rates and increasing life expectancy. For instance, according to the United Nations' World Population Prospects for 2020, the number of people over 65 years may increase from 9.3% in 2020 to more than 16% by 2050. Hence, the prevalence of age-associated chronic diseases and subsequent surgical interventions increased, expanding the market.

Surgical microscopes have become a crucial tool for minimally invasive surgical procedures in dental surgery, otorhinolaryngology, neurosurgery, ophthalmic surgery, and cosmetic surgery. Technological advancements in the products have significantly improved vision, positioning, stability, sizing, and recording capabilities and helped in the integration of image-guided microscope systems for better outcomes.

A surgical microscope offers optimum lighting, 3D visualization, and magnification of deep surgical fields through small approaches. It also benefits surgeons by adjusting their posture while performing complicated and long procedures. These factors are anticipated to propel the market during the forecast period.

However, factors such as lack of skilled professionals and low acceptance due to high cost are likely to hamper the market's growth over the forecast period.

Surgical Microscopes Market Trends

The Gynecology and Urology Segment is Expected to Hold a Significant Market Share

The COVID-19 outbreak negatively impacted the gynecology and urological application segment. The pandemic has majorly impacted surgical services. As per the study titled "COVIDSurg Collaborative," in May 2020, approximately 2.5 million benign urological surgeries were canceled due to the COVID-19 outbreak. However, as elective surgeries and emergency surgical procedures are resuming, the demand for surgical microscopes for urological and gynecology conditions may increase.

The applications of surgical microscopes are wide, among which gynecological and urological applications are the most common, as these practices include many procedures. As the prevalence of urological and gynecological conditions is increasing worldwide, the significance of surgical microscopes is also increasing. For instance, urinary tract infections (UTIs) are one of the most common microbial diseases affecting people of all ages. According to the study titled "Epidemiology of urological infections: a global burden," World Journal of Urology, January 2020, about 150 million people get affected by community-acquired UTIs (CAUTIs). The rising prevalence of target disorders and the complexity of their treatment led to the adoption of advanced techniques involving surgical microscopes.

In gynecological and urological practices, microscopes are used for the detection of cancers, laser surgeries, and diagnostic procedures. The microscopes, like colonoscopy and endoscopy, give access to the inside of the bowel or colon and ease the surgery. Due to the increasing diseases associated with bowel movements, colonoscopy and endoscopy are widely used, which is expected to drive the overall market over the forecast period.

North America is Expected to Dominate the Market Over the Forecast Period

The market growth in the region is vastly attributed to the United States due to the availability of highly advanced equipment, the presence of sophisticated facilities, skilled neurosurgeons and cosmetic surgeons, the increasing number of surgical facilities, the preference for outpatient settings, and the supportive reimbursement framework for medical treatments.

The burden of chronic illnesses, like cancer, cardiovascular diseases (CVD), and neurological diseases, is huge in the United States (US). The Centers for Disease Control and Prevention (CDC) estimates that, between 2010 and 2020, the number of new cancer cases in the country may increase by 24% in men to more than 1 million cases per year and by about 21% in women to more than 900,000 cases per year. Thus, the rising prevalence of chronic disorders and the complexity of their treatment have led to the adoption of advanced techniques that involve the use of surgical microscopes.

The introduction of technologically advanced products is boosting the demand for surgical microscopes as they offer better illumination sources, are more precise, and provide options for customization and technology integration based on the complexity of the procedures. For instance, in September 2020, True Digital Surgery (TDS) and Aesculap Inc. launched Aesculap Aeos Robotic Digital Microscope in the United States. Thus, such technologically advanced product launches are expected to boost the regional market's growth.

However, the rising number of COVID-19 cases may negatively impact the growth of the North American surgical microscopes market due to the affected supply chains of most companies. The usage of equipment like surgical microscopes was temporarily halted to curb the contamination of the virus through surgical equipment. However, as surgical instruments such as colonoscopes and endoscopes are essential components of surgical services, the impact is not expected to be long-term.

Surgical Microscopes Market Competitor Analysis

The surgical microscopes market is highly competitive and consists of several major players. Companies like Alcon, Alltion (Wuzhou) Co. Ltd, ARI Medical Technology Co. Ltd, Metall Zug (Haag-Streit), Danaher Corporation, Olympus Corporation, Seiler Instrument Inc., Takagi Seiko Co. Ltd, Topcon, and Carl Zeiss AG hold a substantial share in the market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Adoption of Minimally Invasive Surgeries
    • 4.2.2 Rise in Geriatric Population and Burden of Chronic Diseases
    • 4.2.3 Technological Advancements in Surgical Microscopes
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Professionals
    • 4.3.2 Low Acceptance Owing to High Costs
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Application
    • 5.1.1 Dentistry
    • 5.1.2 Gynecology and Urology
    • 5.1.3 Ear, Nose, and Throat (ENT)
    • 5.1.4 Neurosurgery and Spine Surgery
    • 5.1.5 Oncology
    • 5.1.6 Ophthalmology
    • 5.1.7 Plastic and Reconstructive Surgery
    • 5.1.8 Other Applications
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Dentist Clinics
    • 5.2.3 Other End Users
  • 5.3 By Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alcon Inc.
    • 6.1.2 Alltion (Wuzhou) Co. Ltd
    • 6.1.3 ARI Medical Technology Co. Ltd
    • 6.1.4 ATMOS MedizinTechnik GmbH & Co. KG
    • 6.1.5 Avante Health Solutions
    • 6.1.6 Carl Zeiss AG
    • 6.1.7 HAAG-STREIT Surgical GmbH
    • 6.1.8 Danaher Corporation (Leica Microsystems)
    • 6.1.9 Metall Zug Group (Haag-Streit)
    • 6.1.10 Olympus Corporation
    • 6.1.11 Optofine Instruments Pvt. Ltd
    • 6.1.12 Seiler Instrument Inc.
    • 6.1.13 Synaptive Medical
    • 6.1.14 Takagi Seiko Co. Ltd
    • 6.1.15 Topcon Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS